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Objective: We investigated the effects of acute volume and RV pressure overload on biventricular function and gene expression of BNP, pro-
inflammatory cytokines (IL-6 and TNF-a), iNOS, growth factors (IGF-1, ppET-1), ACE and Ca2+-handling proteins (SERCA2a, phospholamban
and calsequestrin).
Methods: Male Wistar rats (n =45) instrumented with pressure tip micromanometers in right (RV) and left ventricular (LV) cavities were assigned
to one of three protocols: i) Acute RV pressure overload induced by pulmonary trunk banding in order to double RV peak systolic pressure, during
120 or 360 min; ii) acute volume overload induced by dextran40 infusion (5 ml/h), during 120 or 360 min; iii) Sham. RV and LV samples were
collected for mRNA quantification.
Results: BNP upregulation was restricted to the overloaded ventricles. TNF-a, IL-6, ppET-1, SERCA2a and phospholamban gene activation was
higher in volume than in pressure overload. IGF-1 overexpression was similar in both types of overload, but was limited to the RV. TNF-a and
CSQ mRNA levels were increased in the non-overloaded LV after pulmonary trunk banding. No significant changes were detected in ACE or
iNOS expression. RV end-diastolic pressures positively correlated with local expression of BNP, TNF-a, IL-6, IGF-1, ppET-1 and SERCA2a,
while RV peak systolic pressures correlated only with local expression of IL-6, IGF-1 and ppET-1.
Conclusions: Acute cardiac overload alters myocardial gene expression profile, distinctly in volume and pressure overload. These changes
correlate more closely with diastolic than with systolic load. Nonetheless, gene activation is also present in the non-overloaded LV of selectively
RV overloaded hearts.
D 2005 Elsevier Inc. All rights reserved.Keywords: Gene expression; Growth factors; Hemodynamics; MechanotransductionIntroduction
Cardiac overload is one of the most important stimuli for
heart failure progression (Hoshijima and Chien, 2002; Sussman
et al., 2002). In this disease, chronic activation of growth
promoting signals induces both hypertrophy and a shift in the
gene expression profile of terminally differentiated cardiomyo-
cytes. Changes in the transcription program include regression
to the molecular fetal phenotype, upregulation of pro-inflam-
matory cytokines and growth factors, and disturbed expression
of Ca2+-handling genes. Although hypertrophy contributes, at0024-3205/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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ventricular function preservation, the shift in myocardial gene
expression profile has been associated with the main end-points
of the disease, namely contractile dysfunction, cardiomyocyte
apoptosis and necrosis, myocardial fibrosis and arrythmogen-
esis (Morisco et al., 2003).
Despite extensive knowledge on the molecular mechanisms
of myocardial hypertrophy, much less is known about the acute
response to cardiac overload. There is, however, growing
evidence for disturbed cardiomyocyte gene expression profile.
Pikkarainen et al. observed increased type-B natriuretic peptide
(BNP) mRNA levels 240 min after cyclic stretch of neonatal
ventricular rat cardiomyocytes (Pikkarainen et al., 2003).
Another study demonstrates that transforming growth factor
h1 upregulation induced by acute (30 min) stretch is due to the6) 2633 – 2642
www.e
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(ET-1) (Malhorta et al., 1999). Interestingly, the type of
mechanical stimulus seems to be determinant for the pattern
of molecular adaptation. Yamamoto et al. showed p44/42
MAPK and MEK1/2 activation by cyclic systolic stress, but not
by tension selectively applied in the last third of the cardiac
cycle (Yamamoto et al., 2001).
In the intact heart, acute pressure and volume overload
induced different local growth factor formation (Modesti et al.,
2000). This was associated with distinct hemodynamics and
specific patterns of ventricular remodeling (concentric vs.
eccentric hypertrophy) (Modesti et al., 2000, 2004).
Given that early changes of myocardial gene expression
might underlie ventricular remodeling subsequent to hemody-
namic stress we investigated, in acute volume and RV pressure
overload, the activation of genes previously implicated in
myocardial hypertrophy and contractile dysfunction. Specifi-
cally, we evaluated and correlated biventricular hemodynamics
and myocardial mRNA levels of BNP, pro-inflammatory
cytokines (IL-6 and TNF-a), iNOS, growth factors (IGF-1,
ppET-1), ACE and the Ca2+-handling proteins SERCA2a,
phospholamban (PLB) and calsequestrin (CSQ), after 120 and
360 min of volume overload or selective RV pressure overload,
in the in situ rat heart.
Materials and methods
Experimental design
Animal experiments were performed according to the
Portuguese law on animal welfare and conform to the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals (NIH. Pub. No. 85-23, Revised 1996). Eight weeks
old adult male Wistar rats (n =45; Charles River Laboratories;
Barcelona, Spain) were housed in groups of 5 rats/cage in a
controlled environment under 12 :12 h light–dark cycle at a
room temperature of 22 -C, with a free supply of food and
water.
Rats were randomly assigned to one of three protocols: i)
RV acute pressure overload (P-Band) induced by pulmonary
trunk banding in order to double RV peak systolic pressure
(RVPmax), during 120 (n =7) or 360 (n =8) min; ii) acute
volume overload (Dextran) induced by dextran40 infusion (5
ml/h), during 120 (n =8) or 360 (n =9) min; iii) sham groups of
120 (n =7) and 360 (n =6) min. The mortality rate was 13.3%
in P-Band (2 animals in the 360 min protocol) and 23.5% in
dextran (1 animal in the 120 min protocol and 3 animals in the
360 min protocol). No deaths occurred in Sham.
After hemodynamic instrumentation the animals were
euthanized with anesthetic overdose and transmural RV and
LV free-wall samples were collected and snap frozen in liquid
nitrogen, being stored at 70 -C for mRNA quantification.
Hemodynamic studies
The animals were anesthetized with pentobarbital (6 mg/
100 g, ip), placed over a heating pad, and tracheostomized formechanical ventilation with oxygen-enriched air at 60 cpm,
with a tidal volume of 1 ml/100 g (Harvard Small Animal
Ventilator, model 683). Respiratory rate and tidal volume were
adjusted to keep arterial blood gases and pH within physio-
logical limits. Anesthesia was maintained with an additional
bolus of pentobarbital (2 mg/100 g) as needed. The right
jugular vein was cannulated, under binocular surgical micros-
copy (Wild M651.MS-D, Leica; Herbrugg, Switzerland), for
fluid administration (prewarmed 0.9% NaCl solution) to
compensate for perioperative fluid losses. The heart was
exposed through a median sternotomy, and the pericardium
was widely opened. Pulmonary trunk was dissected and a silk
number 1 was passed around it. RV and LV pressures were
measured with a 2-Fr high-fidelity micromanometer (SPR-324,
Millar Instruments) inserted through the RV free-wall into the
RV cavity and through an apical puncture wound into the LV
cavity. After complete instrumentation, the animal preparation
was allowed to stabilize for 15 min before the beginning of the
experimental protocols. Hemodynamic recordings were made
with respiration suspended at end-expiration. Parameters were
converted on-line to digital data with a sampling frequency of
1 kHz. RV and LV pressure were measured at end-diastole
(RVEDP and LVEDP, respectively) and peak systole (RVPmax
and LVPmax). Peak rates of RV and LV pressure rise (dP /
dtmax) and pressure fall (dP / dtmin) were measured as well. The
relaxation rate was estimated with the time constant s by
fitting the isovolumetric pressure fall to a monoexponential
function.
mRNA Quantification by real-time RT-PCR
Total mRNA was extracted through the guanidium-thiocy-
anate selective silica-gel membrane-binding method (Qiagen
74124) according to the manufacturer’s instructions. Concen-
tration and purity were assayed by spectrophotometry (Eppen-
dorf 6131000.012).
Two-step real-time RT-PCR was used to perform relative
quantification of mRNA, as previously described (Henriques-
Coelho et al., 2004). For each studied mRNA molecule,
standard curves were generated from the correlation between
the amount of starting total mRNA and PCR threshold cycle
(second derivative maximum method) of graded dilutions from
a randomly selected tissue sample (r >0.97). For relative
quantification of specific mRNA levels, 50 ng of total mRNA
from each sample underwent two-step real-time RT-PCR. A
melt curve analysis of each real-time PCR and 2% agarose gels
(0.5 Ag/ml ethidium bromide) were performed to exclude
primer-dimer formation and assess the purity of the amplifica-
tion product. The GAPDH mRNA level was similar in all
experimental groups and was used as an internal control gene.
Results of mRNA quantification are expressed in an arbitrary
unit (AU) set as the average value of the sham group (sham=1
AU), after normalization for GAPDH.
RT (10 min at 22 -C, 50 min at 50 -C and 10 min at 95
-C) was performed in a standard thermocycler (Whatman
Biometra 050-901) with a total volume of 20 Al : 40 U/
reaction of reverse transcriptase (Invitrogen 18064-014), 20
Table 1
Primers used in mRNA quantification by real-time RT-PCR
Gene Primers 5VY3V PCR amplicon
(base pairs)
GAPDH fw: TGGCCTTCCGTGTTCCTACCC 114
rev: CCGCCTGCTTCACCACCTTCT
BNP fw: GGACCAAGGCCCTACAAAAGA 245
rev: CAGAGCTGGGGAAAGAAGAG
IGF-1 fw: CAGACGGGCATTGTGGAT 114
rev: AGTCTTGGGCATGTCAGTGTG
ACE fw: GCAGGCCAGCAGGGTCCACTACAC 196
rev: GACCTCGCCATTCCGCTGATTCT
ppET-1 fw: CCATGCAGAAAGGCGTAAAAG 198
rev: CGGGGCTCTGTAGTCAATGTG
TNF-a fw: GGGGGCCTCCAGAACTCCA 216
rev: TGGGCTACGGGCTTGTCA
IL-6 fw: CCGTTTCTACCTGGAGTTTG 130
rev: GAAGTTGGGGTAGGAAGGAC
iNOS fw: CCCAGCCCAACAACACAGGAT 112
rev: GGGCGGGTCGATGGAGTCA
SERCA2a fw: CGAGTTGAACCTTCCCACAA 240
rev: GGAGGAGATGAGGTAGCGGATGGA
PLB fw: GGCATCATGGAAAAAGTCCA 224
rev: GGTGGAGGGCCAGGTTGTAA
CSQ fw: AGCAGCGTCTCCAAGAA 248
rev: CGTGGTAGTAGAGACAGAGCAAA
R. Roncon-Albuquerque Jr. et al. / Life Sciences 78 (2006) 2633–2642 2635U/reaction of RNase inhibitor (Promega N2515), 30 ng/ml
random primers (Invitrogen 48190-011), 0.5 mM nucleotide
mix (MBI Fermentas R0192), 1.9 mM MgCl2 and 10 mM
DTT. Ten percent of the cDNA yield was used as a template
for real-time PCR (LightCycler, Roche) using SYBR green
(Qiagen 204143) according to the manufacturer’s instructions.
Specific PCR primer pairs for the studied genes are presented
in Table 1.
Statistical analysis
Data are presented as meanTSEM. Hemodynamic data were
compared using two-way repeated measures ANOVA. Differ-
ences in mRNA expression between experimental groups were
analyzed by one-way ANOVA (for normally distributed data)Table 2
RV and LV hemodynamics during acute pulmonary trunk banding
Pulmonary Banding 0 min 60 min 120 min
RV
RVPmax, mm Hg 24.3T1.0 54.1T2.7*
.y 55.1T4.1*.y
dP / dtmax, mm Hg/s 1076T74 2097T128* 2214T318*
dP / dtmin, mm Hg/s 730T58 1199T128 1174T154
RVEDP, mm Hg 0.6T0.3 2.2T1.0 3.5T0.8
s, ms 10.6T1.2 15.6T1.4* 15.8T1.8*
LV
LVPmax, mm Hg 91.0T5.3 86.6T4.0 88.3T3.6
dP / dtmax, mm Hg/s 5531T964 5132T436 5556T675
dP / dtmin, mm Hg/s 4104T575 3588T327 3590T360
LVEDP, mm Hg 1.8T0.4 2.4T0.7 3.2T0.4
y
s, ms 16.1T1.3 15.1T1.1 15.3T0.8
Data are meanTSE. RVPmax and LVPmax, RV and LV peak systolic pressures, respe
respectively; RVEDP and LVEDP, RV and LV end-diastolic pressures, respectively;
yP <0.05 vs. dextran infusion.or by the corresponding non-parametric test (Kruskal–Wallis
ANOVA on Ranks). Linear regression and Pearson correlation
coefficients were employed to correlate variables. When
necessary, the test was preceded by a square root transform
to obtain a normal distribution. Statistical significance was set
at P <0.05.
Results
Biventricular hemodynamics in acute cardiac overload
Acute pulmonary banding and dextran infusion induced
distinct hemodynamic responses. Pulmonary banding (Table 2)
induced a selective pressure overload of the RV, with no
significant changes in LV hemodynamics. Pulmonary trunk
was constricted until basal RVPmax was doubled. This was
accompanied by an augmentation of RV-dP / dtmax and slower
relaxation as denoted by the prolongation of the RV time
constant s. RVEDP increased significantly at 240 and 300 min.
On the other hand, acute intravascular volume expansion with
dextran (Table 3) progressively increased EDP and s in both
ventricles, while Pmax was selectively increased in the RV.
Hemodynamics of sham operated animals remained unal-
tered throughout the experimental protocol (Table 4). Heart rate
was similar in all the studied groups (298T8.9 bpm) and did
not vary during the experimental protocols. Biventricular
hemodynamic data from the animals euthanized at 120 min
were similar to their counterparts euthanized at 360 min, and
therefore are not presented.
Biventricular gene expression profile in acute cardiac overload
Myocardial gene expression profile was distinct in P-Band
and Dextran groups. BNP was upregulated at 360 min in the
overloaded ventricles (Fig. 1). In fact, both pulmonary banding
and dextran infusion raised BNP mRNA levels in the RV, while
only dextran infusion modified BNP expression in the LV.
Unexpectedly, we observed BNP downregulation in the LV
after 120 min of dextran infusion, which reversed at 360 min.180 min 240 min 300 min 360 min
54.2T4.1*.y 56.3T3.9*.y 50.0T5.2*.y 49.2T4.6*.
2146T287* 2141T227* 1906T255* 1862T287*
1100T142 1057T110 1022T103 1000T147
4.0T0.6 5.0T0.9* 4.5T1.1* 4.3T1.2*
17.2T1.5* 17.2T1.3* 17.5T1.3* 16.8T1.0*
90.7T3.1 90.0T1.9 90.0T2.8 82.2T4.2
5551T729 5834T488 5619T658 4894T746
3212T299 3231T286 3233T234 2798T308
3.5T0.4y 3.5T0.4y 3.1T0.3y 3.7T0.7y
16.8T1.2 17.3T1.2 17.2T1.0y 16.9T0.7y
ctively; dP / dtmax and dP / dtmin, peak rates of ventricular pressure rise and fall,
s, time constant of isovolumetric relaxation; *P <.05 vs. 0V; .P <0.05 vs. sham;
Table 3
RV and LV hemodynamics during dextran e.v. infusion
Dextran40 0 min 60 min 120 min 180 min 240 min 300 min 360 min
RV
RVPmax, mm Hg 25.9T1.0 27.7T1.2
y 32.1T2.1y 34.8T2.5*y 40.4T2.3*y 40.9T2.7*y 42.4T3.3*
dP / dtmax, mm Hg/s 1032T79 1230T108 1224T143 1282T152 1306T151 1261T149 1318T166
dP / dtmin, mm Hg/s 833T138 1160T154 1162T149 1125T157 1241T166 984T141 999T153
RVEDP, mm Hg 1.1T0.6 1.3T1.0 4.0T1.1 5.0T1.5* 7.2T2.3*
. 6.9T2.2* 6.9T2.5*
s, ms 12.2T0.8 13.0T1.0 14.5T1.5 15.5T1.3 16.5T1.8* 18.3T1.6* 19.7T1.8*
LV
LVPmax, mm Hg 97.8T7.9 108.4T6.2 109.2T8.5 102.5T9.3 101.5T6.9 81.6T7.1 81.4T7.0
dP / dtmax, mm Hg/s 4614T567 6625T787 6433T901 5718T740 5370T709 3863T480 3824T499
dP / dtmin, mm Hg/s 3714T465 4543T601 4162T572 3684T553 3432T377 2398T387 2409T396
LVEDP, mm Hg 3.0T1.2 5.7T2.4* 6.7T1.5*
.y 7.3T1.6*.y 7.9T2.3*.y 6.2T1.7*y 5.9T1.8*y
s, ms 14.4T0.3 16.2T0.6 17.9T1.2* 19.3T2.0* 21.0T1.5* 22.2T1.2*.y 23.0T1.1*.y
Data are meanTSE. RVPmax and LVPmax, RV and LV peak systolic pressures, respectively; dP / dtmax and dP / dtmin, peak rates of ventricular pressure rise and fall,
respectively; RVEDP and LVEDP, RV and LV end-diastolic pressures, respectively; s, time constant of isovolumetric relaxation; *P <.05 vs. 0V; .P <0.05 vs. Sham;
yP <0.05 vs. pulmonary trunk banding.
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factor expression (Fig. 1). In the RV we observed IGF-1
upregulation at 360 min, similar in Dextran and P-Band
groups. Regarding ppET-1, there was a pronounced upregula-
tion of its myocardial expression 360 min after dextran
infusion, both in RV and LV, whilst pulmonary trunk banding
promoted a lower increase of ppET-1 mRNA levels restricted
to the RV. We did not detect changes in myocardial expression
of ACE.
Myocardial gene activation of IL-6 and TNF-a was higher
in volume than in pressure overload (Fig. 2). It should be
noted that TNF-a upregulation was also observed at 360 min in
the non-overloaded LV of P-Band. Accordingly, a strong
positive correlation between RV and LV mRNA levels of
TNF-a (r =0.81; p <0.0001) was observed in all experimental
protocols. We did not detect changes in iNOS myocardial
expression.
Regarding the myocardial expression of Ca2+-handling
proteins (Fig. 3), SERCA2a and PLB were upregulated in the
RV after 360 min of dextran infusion, while pulmonary trunk
banding did not significantly change mRNA levels of theseTable 4
RV and LV hemodynamics in sham
Sham 0 min 60 min 120 min
RV
RVPmax, mm Hg 27.0T1.6 27.2T1.9 26.4T1.7
dP / dtmax, mm Hg/s 1460T126 1462T193 1471T213
dP / dtmin, mm Hg/s 985T148 1021T214 1033T199
RVEDP, mm Hg 1.7T0.9 3.0T1.1 2.5T0.9
s, ms 12.3T0.9 13.1T0.6 13.1T0.8
LV
LVPmax, mm Hg 95.5T6.0 102T9.1 96.0T10.2
dP / dtmax, mm Hg/s 5517T658 6675T1002 6201T1130
dP / dtmin, mm Hg/s 3905T301 4718T601 4322T743
LVEDP, mm Hg 2.4T0.4 2.5T0.5 2.7T0.7
s, ms 15.6T0.6 15.3T0.4 15.6T0.6
Data are meanTSE. RVPmax and LVPmax, RV and LV peak systolic pressures, respe
respectively; RVEDP and LVEDP, RV and LV end-diastolic pressures, respectivelygenes. SERCA2a overexpression was also present in the LV at
360 min of Dextran group. CSQ, assayed as a possible internal
control gene, varied significantly from Sham both in P-Band
and Dextran.
Correlation of gene expression with end-diastolic and peak
systolic pressures
mRNA levels of BNP, TNF-a and SERCA2a in the RV
selectively correlate with RVEDP, but not with RVPmax, in all
experimental groups (Fig. 4). For IGF-1, ppET-1 and IL-6,
positive correlations were found between RV mRNA levels and
both RVEDP and RVPmax (Fig. 5).
Dextran infusion elevated EDP and altered myocardial gene
expression in both ventricles. In this experimental protocol,
significant correlations were observed between RV and LV
mRNA levels of the following genes: BNP (r =0.49; p =0.018),
ppET-1 (r=0.75; p =0.0002), TNF-a (r =0.77; p <0.0001), IL-
6 (r =0.83; p <0.0001) and SERCA2a (r=0.67; p =0.0006). In
this experimental protocol, PLB and IGF-1 upregulation was
restricted to the RV. For these two genes, expression levels180 min 240 min 300 min 360 min
28.5T2.2 30.8T2.0 30.7T1.8 29.9T2.0
1445T213 1486T179 1473T174 1437T234
1073T193 1227T134 1316T177 1316T189
2.1T0.8 2.4T0.7 2.5T0.8 2.7T1.1
12.9T0.9 13.1T1.1 13.5T0.8 14.0T1.2
95.7T9.3 95.1T6.9 92.1T6.3 92.2T6.8
5860T918 5637T399 5622T419 5339T419
4140T570 3926T419 3663T358 3348T252
3.0T0.8 3.2T0.3 3.5T0.4 3.9T0.5
15.8T0.6 16.1T0.6 16.1T0.7 16.6T0.6
ctively; dP / dtmax and dP / dtmin, peak rates of ventricular pressure rise and fall,
; s, time constant of isovolumetric relaxation.
B
N
P/
G
AP
DH
 
m
RN
A 
(A
U)
0
2
4
6
8
10
12
14
16
120 min
360 min
*‡
A
IG
F-
1/
G
AP
DH
 
m
R
N
A
 (A
U)
0
2
4
6
8
10
12
14
16B
C
*† *†
*†
* *
P-BandDextran
RV
P-BandDextran
LV
pp
ET
-1
/GA
PD
H 
m
R
N
A
 (A
U)
0
2
4
6
8
10
12
14
16
*†‡
*
*†‡
*
§
P-BandDextran
RV
P-BandDextran
LV
AC
E/
G
AP
DH
 
m
R
N
A
 (A
U)
0
2
4
6
8
10
12
14
16 D
Fig. 1. Biventricular expression of BNP (A), IGF-1 (B), ppET-1 (C) and ACE (D), 120 and 360 min after dextran infusion (Dextran) or pulmonary trunk banding (P-
Band). Results are presented in arbitrary units (sham=1 AU). *P <0.05 vs. Sham; .P <0.05 vs. 120 min; -P <0.05 vs. P-Band; ‘P <0.05 vs. RV.
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IGF-1: r=0.67, p =0.0004).
Discussion
In the present study we demonstrate acute modulation of
gene expression, as early as 120 min, after volume and RV
pressure overload in the in situ rat heart. This modulation
encompassed BNP, growth factors, pro-inflammatory cyto-
kines, Ca2+-handling proteins, and although it mainly involved
the overloaded ventricles, it also affected the non-overloaded
myocardium. Changes in myocardial gene expression correlat-
ed with systolic and diastolic pressures and were distinct in
volume and pressure overload.
Dextran infusion induced a progressive increase of EDP and
s in both ventricles, which was accompanied by concurrent
upregulation of BNP, ppET-1, TNF-a, IL-6 and SERCA2a in
RVand LV. Pmax elevation, however, was restricted to the RV, a
feature also observed in the aorta-cava fistula model (Modesti
et al., 2004). The selective increase of PLB and IGF-1 mRNA
in the RV could indicate that, in the setting of a volume
overload, some degree of concomitant pressure overload might
be required for the upregulation of these genes.
In our study, TNF-a gene activation was present in the
overloaded ventricles, in accordance with the results of
previous reports (Baumgarten et al., 2002; Kapadia et al.,
1997). However, TNF-a was not upregulated in chronic
pressure (Baumgarten et al., 2002) and volume (Dai et al.,2004) overload, despite persistent hemodynamic stress. It was
suggested that sustained cardiac overload could induce the
activation of tristetraprolin, a zinc protein which destabilize
TNF-a mRNA in various cell types (Baumgarten et al., 2002;
Dai et al., 2004).
Interestingly, we observed TNF-a upregulation in the
nonoverloaded LV of rats subjected to pulmonary trunk
banding indicating gene activation by load-independent
mechanisms, most likely paracrine or endocrine mediation. In
fact, TNF-a upregulation in the infarcted myocardium induces
cytokine upregulation in the neighbouring myocardium (Nian
et al., 2004) and early post-ischemic cardiac lymph activates
cytokine expression in canine mononuclear cells, an effect that
is lost after incubation with a neutralizing antibody to TNF-a
(Frangogiannis et al., 2002). Moreover, TNF-a is induced in
the normal recipient heart of rats after heterotopic post-
myocardial infarct heart transplants (Nakamura et al., 2003).
The pattern of gene response for TNF-a was not mimicked
by IL-6. IL-6 activation was restricted to the overloaded
ventricles, with no gene activation in the LV of P-Band.
Although TNF-a is a well-accepted upstream cytokine
inducing IL-6 gene activation, our results suggest that, in the
absence of myocardial overload, acute upregulation of the
former is not accompanied by overexpression of the latter. This
might not be surprising since IL-6 upregulation was already
observed in chronic volume overload in the absence of
concomitant TNF-a activation (Dai et al., 2004), further
dissociating the expression of these two genes.
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R. Roncon-Albuquerque Jr. et al. / Life Sciences 78 (2006) 2633–26422638Acute upregulation of IL-6 and TNF-a was more pro-
nounced with volume than with pressure overload. Interest-
ingly, these cytokines have been implicated in the development
of the eccentric hypertrophy phenotype. Transgenic mice with
cardiac restricted overexpression of TNF-a present progressive
LV dilation (Sivasubramanian et al., 2001), and the activation
of IL-6 receptor transmembranar domain gp130 in isolated
neonatal rat cardiomyocytes induces sarcomere longitudinal
growth (Wollert et al., 1996).
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Fig. 4. Correlations between RV end-diastolic pressure (left panels) and RV peak-systolic pressure (right panels) with mRNA levels of BNP (A), TNF-a (B) and
SERCA2a (C) in Sham (r), P-Band 120 (?) and 360 min (>), and Dextran 120 (n) and 360 min (g) groups, in the RV. The hemodynamic parameters were
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R. Roncon-Albuquerque Jr. et al. / Life Sciences 78 (2006) 2633–2642 2639RV IGF-1 overexpression in P-Band was similar to Dextran,
in accordance with previous studies showing an upregulation
of this gene in pressure and volume overload (Modesti et al.,
2000, 2004). Given its pro-hypertrophic and anti-apoptotic
actions, IGF-1 might contribute to myocardial adaptation to
cardiac overload (Tanaka et al., 1998; Welch et al., 2002).
Differently, dextran infusion induced a higher increase of
ppET-1 expression than pulmonary trunk banding. This
somewhat diverges from what was previously described for
distinct types of acute LV overload (Modesti et al., 2000). In
this study, only acute aortic banding induced ppET-1 upregula-
tion, with no differences detected in the aorto-caval fistulagroup. This could depend on the distinct features of RVand LV,
as well as on the mixed pressure–volume load faced by the RV
after dextran infusion. The mixed pressure–volume load to
which the RV is subjected has also been proposed to explain
selective RV ppET-1 activation in chronic volume overload
(Modesti et al., 2004).
Natriuretic peptide upregulation after mechanical and phar-
macological stimulation is used as a molecular marker of
cardiac hypertrophic gene response (van Wamel et al., 2000),
and represents a regression to the molecular fetal phenotype
(Takahashi et al., 1992). The present study shows increased
BNP mRNA levels in acute pressure and volume overloaded
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out in the isolated rat heart (Magga et al., 1997) or in neonatal
rat ventricular cardiomyocytes (van Wamel et al., 2000).
Impaired cardiomyocyte Ca2+-handling has been implicated
in the origin of contractile dysfunction during heart failure
progression (Bers, 2002). Decreased expression of the major
Ca2+-handling protein SERCA2a (Hasenfuss et al., 1994) and
enhanced inhibition by its major regulator PLB have been
demonstrated in advanced heart failure (Sande et al., 2002).
Despite extensive evidence for altered expression of Ca2+-
handling proteins in heart failure, the acute response to cardiac
overload remains unknown. To our knowledge, the present
study is the first to demonstrate SERCA2a and PLB upregula-
tion by acute volume overload, in vivo. Unlike what has been
described in chronic overload, with decreased SERCA2aexpression in both pressure (Feldman et al., 1993) and volume
overload (Nediani et al., 2002), a different response in acute
pulmonary banding and dextran infusion was observed, with
SERCA2a upregulation restricted to the latter. This early
upregulation would fit in a model of biphasic expression of
these genes during the time course of adaptation to volume
overload. Myocardial expression of the major Ca2+-binding
protein of the sarcoplasmic reticulum CSQ was also altered in
acute cardiac overload. This diverges from the stable mRNA
levels observed in heart failure, with differences detected only
at the post-translational level (Kiarash et al., 2004).
Previous works showed that acute mechanical stretch
modulates cardiomyocyte gene expression in vitro (Palmieri
et al., 2002; van Wamel et al., 2000). In our study, we found
significant in vivo correlations between myocardial mRNA
R. Roncon-Albuquerque Jr. et al. / Life Sciences 78 (2006) 2633–2642 2641levels of several genes and both diastolic and systolic
pressures, although the number and strength of these
correlations were higher with the former. Since the studied
genes have been implicated in myocardial function and
remodeling, it is plausible that different patterns of gene
expression in acute cardiac overload might underlie distinct
functional and hypertrophic phenotypes in chronic pressure
and volume overload.
Acronyms
ACE Angiotensin converting enzyme
BNP Type B natriuretic peptide
CSQ Calsequestrin
dP / dtmax Peak rate of pressure rise
dP / dtmin Peak rate of pressure fall
GAPDH Glyceraldehyde-3-phosphate dehydrogenase
IGF-1 Insulin-like growth factor 1
IL-6 Interleukin 6
iNOS Inducible nitric oxide synthase
LV Left ventricle or left ventricular
LVEDP LV end-diastolic pressure
LVPmax Peak systolic LV pressure
P-Band Pulmonary trunk banding
PLB Phospholamban
ppET-1 Pre-pro-endothelin 1
RV Right ventricle or right ventricular
RVEDP RV end-diastolic pressure
RVPmax Peak systolic RV pressure
SERCA2a Sarcoplasmic reticulum Ca2+ ATPase
s Time constant of isovolumetric relaxation
TNF-a Tumour necrosis factor alpha
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